U.S. markets close in 5 hours 52 minutes
  • S&P 500

    4,642.73
    -12.54 (-0.27%)
     
  • Dow 30

    34,945.64
    -190.30 (-0.54%)
     
  • Nasdaq

    15,817.09
    +34.26 (+0.22%)
     
  • Russell 2000

    2,221.32
    -20.65 (-0.92%)
     
  • Crude Oil

    67.70
    -2.25 (-3.22%)
     
  • Gold

    1,804.90
    +19.70 (+1.10%)
     
  • Silver

    23.23
    +0.37 (+1.63%)
     
  • EUR/USD

    1.1373
    +0.0080 (+0.71%)
     
  • 10-Yr Bond

    1.4290
    -0.1010 (-6.60%)
     
  • GBP/USD

    1.3361
    +0.0050 (+0.37%)
     
  • USD/JPY

    112.6780
    -0.9300 (-0.82%)
     
  • BTC-USD

    58,459.06
    +1,477.59 (+2.59%)
     
  • CMC Crypto 200

    1,489.50
    +46.72 (+3.24%)
     
  • FTSE 100

    7,083.45
    -26.50 (-0.37%)
     
  • Nikkei 225

    27,821.76
    -462.16 (-1.63%)
     

3 No-Brainer Biotech Stocks to Buy Right Now

·6 min read
3 No-Brainer Biotech Stocks to Buy Right Now
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here's why they selected Regeneron Pharmaceuticals (NASDAQ: REGN), Vertex Pharmaceuticals (NASDAQ: VRTX), and Viatris (NASDAQ: VTRS). Prosper Junior Bakiny (Regeneron Pharmaceuticals): Shares of Regeneron dropped like a rock amid September's broad market declines.